Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Hexal Brand of Prednisone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 758Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AGAMREE Shows Long-Term Safety, Efficacy in Duchenne Disease
    AGAMREE Shows Long-Term Safety, Efficacy in Duchenne Disease

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251502/0/en/AGAMREE-vamorolone-Data-Presented-at-MDA-2026-Confirm-Comparable-Long-Term-Effectiveness-for-up-to-8-Years-of-Treatment-with-Clinically-Meaningful-Safety-Advantages-in-Duchenne-Mus.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Incyte to seek FDA approval for Monjuvi in front-line DLBCL
    Incyte to seek FDA approval for Monjuvi in front-line DLBCL

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260105730167/en/Incyte-Announces-Positive-Topline-Results-from-Pivotal-Study-of-Tafasitamab-MonjuviMinjuvi-as-a-First-line-Treatment-for-Diffuse-Large-B-Cell-Lymphoma

    BUSINESSWIRE
    05 Jan 2026
    Share Share
    Dr Reddys`s Generics Prednisone Receives Approval in US
    Dr Reddys`s Generics Prednisone Receives Approval in US

    01 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219477

    FDA
    01 Oct 2025
    Share Share
    Dr. Reddy lab`s Generics Prednisone Receives Tentative Approval in US
    Dr. Reddy lab`s Generics Prednisone Receives Tentative Approval in US

    08 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218035

    FDA
    08 Aug 2024
    Share Share
    Vincerx Announces Compelling Efficacy of Enitociclib with Venetoclax
    Vincerx Announces Compelling Efficacy of Enitociclib with Venetoclax

    07 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/07/2805016/0/en/Vincerx-Pharma-Announces-Compelling-Clinical-Efficacy-of-Enitociclib-in-Combination-with-Venetoclax-and-Prednisone-in-Lymphoma.html

    GLOBENEWSWIRE
    07 Jan 2024
    Share Share
    FDA approves J&J's PARP combo drug Akeega for prostate cancer
    FDA approves J&J's PARP combo drug Akeega for prostate cancer

    12 Aug 2023

    // FDA

    https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-niraparib-and-abiraterone-acetate-plus-prednisone-brca-mutated-metastatic-castration?utm_medium=email&utm_source=govdelivery#:~:text=On%20August%2011%2C%202023%2C%20the,as%20determined%20by%20an%20FDA%2D

    FDA
    12 Aug 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.